QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
CVE:VIV

Avivagen (VIV) Stock Forecast, Price & News

C$0.01
+0.01 (+100.00%)
(As of 05:20 PM ET)
Compare
Today's Range
C$0.01
▼
C$0.01
50-Day Range
C$0.01
▼
C$0.02
52-Week Range
C$0.01
▼
C$0.17
Volume
4,020 shs
Average Volume
70,027 shs
Market Capitalization
C$776,900.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsHeadlinesOptions Chain

VIV stock logo

About Avivagen (CVE:VIV) Stock

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

VIV Price History

VIV Stock News Headlines

August 25, 2023 | theglobeandmail.com
Closing Bell: Avivagen Inc flat on Friday (VIV)
July 31, 2023 | technews.tmcnet.com
Avivagen Provides Corporate Updates
September 21, 2023 | Chaikin Analytics (Ad)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
July 29, 2023 | theglobeandmail.com
Closing Bell: Avivagen Inc up on Friday (VIV)
July 24, 2023 | finance.yahoo.com
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock Product
July 19, 2023 | theglobeandmail.com
Closing Bell: Avivagen Inc flat on Tuesday (VIV)
July 15, 2023 | theglobeandmail.com
Avivagen: Top 10 Undervalued Growth Stocks on TSX-V (VIV)
June 27, 2023 | theglobeandmail.com
Closing Bell: Avivagen Inc down on Monday (VIV)
September 21, 2023 | Chaikin Analytics (Ad)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
May 25, 2023 | msn.com
An existing Avivagen customer increases order size
May 25, 2023 | finance.yahoo.com
Avivagen Announces Significant Increase in Sales to an Existing Customer
May 23, 2023 | sg.finance.yahoo.com
Avivagen Inc. (VIV.V)
May 18, 2023 | tmcnet.com
Avivagen Announces Review of Strategic Alternatives
April 27, 2023 | theglobeandmail.com
Closing Bell: Avivagen Inc down on Thursday (VIV)
April 19, 2023 | finance.yahoo.com
Avivagen Announces AGM Results
April 7, 2023 | theglobeandmail.com
Closing Bell: Avivagen Inc flat on Thursday (VIV)
April 6, 2023 | theglobeandmail.com
Closing Bell: Avivagen Inc flat on Wednesday (VIV)
March 28, 2023 | finance.yahoo.com
Avivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSO
March 18, 2023 | finance.yahoo.com
Avivagen First Quarter 2023 Earnings: CA$0.015 loss per share (vs CA$0.027 loss in 1Q 2022)
February 21, 2023 | msn.com
Avivagen reports FY results
February 21, 2023 | finance.yahoo.com
Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth
January 20, 2023 | finance.yahoo.com
Avivagen Inc. (VIVXF) Interactive Stock Chart - Yahoo Finance
January 13, 2023 | uk.finance.yahoo.com
Avivagen Inc. (VIVXF)
December 26, 2022 | baystreet.ca
Merry Christmas
December 22, 2022 | yahoo.com
Avivagen Inc. Announces Securities for Service Agreements With CEO and CSO
October 21, 2022 | finance.yahoo.com
Avivagen Inc. Announces Closing of First Tranche of a Non-Brokered Private Placement of Shares for Proceeds of up to $1.0 Million
October 14, 2022 | finance.yahoo.com
Avivagen Inc. Announces Proposed Non-Brokered Private Placement of Common Shares for Proceeds of up to $1.0 Million
See More Headlines
Receive VIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter.

VIV Company Calendar

Today
9/21/2023
Next Earnings (Estimated)
9/22/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
CVE:VIV
CUSIP
N/A
CIK
N/A
Web
www.avivagen.com
Phone
613-949-8164
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-5,610,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-151.30%

Debt

Debt-to-Equity Ratio
2,402.32
Current Ratio
0.04
Quick Ratio
0.30

Sales & Book Value

Annual Sales
C$403,780.00
Price / Sales
1.92
Cash Flow
C$0.00 per share
Price / Cash Flow
12.14
Book Value
C($0.11) per share
Price / Book
-0.09

Miscellaneous

Outstanding Shares
77,690,000
Free Float
N/A
Market Cap
C$776,900.00
Optionable
Optionable
Beta
1.21
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. G. F. Kym Anthony (Age 67)
    CEO & Vice Chairman
    Comp: $361.06k
  • Dr. Graham Burton Ph.D.
    Co-Founder, Chief Scientific Officer & Director
  • Mr. Ira Levy
    Interim Chief Financial Officer
  • Dr. James Nickerson Ph.D.
    Pres and Exec. VP of Bus. Devel. & Product Innovation
  • Mr. Drew Basek
    Director of Investor Relations
  • Ms. Tracy Gillett BVSC
    Director of Companion Animal & Marketing Mang.

Key Competitors

View All Competitors













VIV Stock - Frequently Asked Questions

How have VIV shares performed in 2023?

Avivagen's stock was trading at C$0.08 on January 1st, 2023. Since then, VIV stock has decreased by 87.5% and is now trading at C$0.01.
View the best growth stocks for 2023 here.

When is Avivagen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, September 22nd 2023.
View our VIV earnings forecast.

What other stocks do shareholders of Avivagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avivagen investors own include Astrotech (ASTC), Arcturus Therapeutics (ARCT), Aptose Biosciences (APTO), Appili Therapeutics (APLIF), Argan (AGX), Applied Genetic Technologies (AGTC), AES (AES) and AbbVie (ABBV).

What is Avivagen's stock symbol?

Avivagen trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VIV."

How do I buy shares of Avivagen?

Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Avivagen's stock price today?

One share of VIV stock can currently be purchased for approximately C$0.01.

How much money does Avivagen make?

Avivagen (CVE:VIV) has a market capitalization of C$776,900.00 and generates C$403,780.00 in revenue each year. The company earns C$-5,610,000.00 in net income (profit) each year or C($0.07) on an earnings per share basis.

How can I contact Avivagen?

Avivagen's mailing address is Av Engenheiro Luis Carlos Berrini, 1376 32 andar, Sao Paulo, Sao Paulo 04.571-936. The official website for the company is www.avivagen.com. The company can be reached via phone at 613-949-8164.

This page (CVE:VIV) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -